INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

76,350 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SS
Stellato StevenSee Remarks
KNTKKinetik Holdings Inc.
Grant or award
A—
10.8K sh
Aug 7, 2026Aug 10, 2026
Page 677 of 1909
← PrevNext →
traded Aug 7, 2026
+3d
SEC Form 4

Evidence

9
Murdoch Lachlan KDirector, Executive Chair, CEO
FOXFox Corp
Grant or award
A—
147.2K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
1.60M sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
112.7K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
1.60M sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
SG
Sotiros GeorgeVP - INFORMATION SYSTEMS
WEYSWEYCO GROUP INC
Option exercise
M$20K
780 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
LT
Lavin Michael T.President
CPSSCONSUMER PORTFOLIO SERVICES, INC.
Option exercise
M—
90.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
HT
Howard TrevorSee Remarks
KNTKKinetik Holdings Inc.
Grant or award
A—
10.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
124.8K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
124.8K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
CG
Combs Michael GCEO & President
CRVLCORVEL CORP
Grant or award
A—
1,500 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
AS
Agrawal SundeepDirector
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
578.5K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
SG
Sotiros GeorgeVP - INFORMATION SYSTEMS
WEYSWEYCO GROUP INC
Option exercise
M$22K
1,200 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
124.8K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
676.2K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
OY
Ofek Amir YechielDirector
GILTGILAT SATELLITE NETWORKS LTD
Option exercise
M—
8,334 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
AS
Agrawal SundeepDirector
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
578.5K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
WM
Wall MatthewSee Remarks
KNTKKinetik Holdings Inc.
Grant or award
A—
12.2K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
HR
Holmes Joseph R.VP & Chief Accounting Officer
TMOTHERMO FISHER SCIENTIFIC INC.
Option exercise
M—
420 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
1.60M sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
113.4K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
TS
Tomsic StevenChief Financial Officer
FOXFox Corp
Grant or award
A—
40.2K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
AS
Agrawal SundeepDirector
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
23.9K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
RB
Rayhill BrianDirector
CPSSCONSUMER PORTFOLIO SERVICES, INC.
Option exercise
M—
30.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
SG
Sotiros GeorgeVP - INFORMATION SYSTEMS
WEYSWEYCO GROUP INC
Option exercise
M$29K
1,200 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
MW
McIntosh Greg WEVP, Chief Commercial Officer
IRMIRON MOUNTAIN INC
Option exercise · 10b5-1 plan
M$253K
6,839 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
PP
Price Dwayne PChief Accounting Officer
OPLNOPENLANE, Inc.
Tax withholding
F$4,659
126 sh
Aug 9, 2026Aug 10, 2026
traded Aug 9, 2026
+1dSEC Form 4

Evidence

8
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Tax withholding
F$386K
3,288 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

7
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
49.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

7
SS
Sanders A ShaneDirector
CVLTCOMMVAULT SYSTEMS INC
Grant or award · 10b5-1 plan
A—
1,761 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

6
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$203K
1,200 sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

6
AD
Agarwal DeveshChief Operating Officer
BANDBandwidth Inc.
Option exercise
M—
7,370 sh
Aug 8, 2026Aug 10, 2026
traded Aug 8, 2026
+2dSEC Form 4

Evidence

5
QS
Quinton SashaEVP, Pres. CBG
SCHLSCHOLASTIC CORP
Option exercise
M—
22.2K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

5
BS
Benzaquen Jacob ShlomoPrincipal Accounting Officer
VRMVroom, Inc.
Grant or award
A—
7,500 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
RD
Rico Robert DanielChief Accounting Officer
GLXYGalaxy Digital Inc.
Option exercise
M—
710 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
RD
Rico Robert DanielChief Accounting Officer
GLXYGalaxy Digital Inc.
Option exercise
M—
18.8K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
Murdoch Keith RupertChairman Emeritus
FOXFox Corp
Grant or award
A—
35.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

5
CC
Corrales Anna-Lisa ChristinaCLO, CCO, Secretary
VRMVroom, Inc.
Grant or award
A—
22.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
22.7K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

5
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
22.7K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence